Felix W.
- Country
- Germany
- Department
- Klinik für Herz- und Gefäßchirurgie
Research Overview
Data & Insights
Has run more than one trial at 0 of 16 partner sites.
Specializations
Cardiovascular Disease Therapeutics
Focus on interventions that reduce major adverse cardiovascular events in patients with acute coronary syndromes and chronic atherosclerotic disease.
- Antiplatelet optimization
- Anticoagulation strategies
- Valve disease management
Integrates pharmacologic and procedural approaches to improve cardiac outcomes.
Lipoprotein(a) Targeted Therapies
Investigation of agents that lower Lp(a) levels to mitigate atherosclerotic risk.
- RNA‑based inhibitors
- Monoclonal antibodies
- Clinical impact on valve calcification
Emphasizes long‑term cardiovascular risk reduction through lipid modulation.
Hypertrophic Cardiomyopathy Management
Research on pharmacologic and genetic therapies for obstructive and non‑obstructive hypertrophic cardiomyopathy.
- Mavacamten efficacy
- Gene therapy for Danon disease
- Exercise capacity outcomes
Targets symptom relief and disease progression in diverse patient ages.
Renal Protection in Cardiac Surgery
Study of strategies to prevent acute kidney injury and preserve renal function during and after cardiac procedures.
- Ilofotase alfa
- RMC‑035 dosing
- Vasopressor selection impact
Addresses postoperative renal outcomes in high‑risk surgical cohorts.
Inflammation Modulation in Atherosclerosis
Evaluation of anti‑inflammatory agents that target cytokine pathways to lower systemic inflammation and cardiovascular risk.
- Ziltivekimab
- DFV890 and MAS825 trials
- CRP reduction outcomes
Links inflammatory control with event reduction in patients with established disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.